|
Volume 271, Number 51,
Issue of December 20, 1996
pp. 32825-32833
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Cryptic Antigenic Determinants on the Extracellular Pyruvate
Dehydrogenase Complex/Mimeotope Found in Primary Biliary
Cirrhosis
A PROBE BY AFFINITY MASS SPECTROMETRY
(Received for publication, June 18, 1996, and in revised form, September 12, 1996)
Tai-Tung
Yip
§
,
Judy
Van de Water
¶
,
M. Eric
Gershwin
¶
,
Ross L.
Coppel
and
T. William
Hutchens
From the Department of Food Science and Technology
and the ¶ Department of Rheumatology, Allergy and
Clinical Immunology, University of California Davis, School of
Medicine, Davis, California 95616, § Molecular Analytical
Systems, Davis, California 95616, and the Department of Microbiology,
Monash University, Victoria, Australia 3168
Affinity mass spectrometry (AMS) was used to
evaluate the structural diversity of the E2 component of pyruvate
dehydrogenase complex (PDC) in normal and diseased liver cells,
including those from patients with the autoimmune disease primary
biliary cirrhosis (PBC). Two different antibodies to PDC-E2, the
immunodominant mitochondrial autoantigen in patients with PBC, were
used. AMS was performed directly on frozen liver sections
and purified bile duct epithelial cells. Mass spectrometric signals
associated with the molecular recognition of PBC-specific antigenic
determinants were enhanced by an in situ enzyme-linked
signal amplification process. Samples from patients with PBC gave
strong positive signals for the antigen(s) recognized by the monoclonal
antibody C355.1. Conversely, tissues from normal and disease controls
showed only a minimal signal. AMS was used to identify specific
antigenic determinants within the E2 component of PDC for comparison
with unknown antigenic determinants observed by affinity capture with C355.1 monoclonal antibody from PBC samples. PDC components bound to
C355.1 were mapped and identified by mass before dissociation from the
E2 component. A similar approach was used to identify unknown antigenic
determinants associated with PBC. We believe AMS may be an important
new approach with wide application to the identification of molecules
associated with a number of disease states.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Zhang, R. Sprung, J. Pei, X. Tan, S. Kim, H. Zhu, C.-F. Liu, N. V. Grishin, and Y. Zhao
Lysine Acetylation Is a Highly Abundant and Evolutionarily Conserved Modification in Escherichia Coli
Mol. Cell. Proteomics,
February 1, 2009;
8(2):
215 - 225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. R. Srinivas, M. Verma, Y. Zhao, and S. Srivastava
Proteomics for Cancer Biomarker Discovery
Clin. Chem.,
August 1, 2002;
48(8):
1160 - 1169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Migliaccio, A. Nishio, J. Van de Water, A. A. Ansari, P. S. C. Leung, Y. Nakanuma, R. L. Coppel, and M. E. Gershwin
Monoclonal Antibodies to Mitochondrial E2 Components Define Autoepitopes in Primary Biliary Cirrhosis
J. Immunol.,
November 15, 1998;
161(10):
5157 - 5163.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|